Login to Your Account

Pharma: Clinic Roundup

Monday, April 23, 2012
• Boehringer Ingelheim GmbH, of Ingelheim, Germany, launched a worldwide registry to study treatment regimes for stroke prevention in nonvalvular atrial fibrillation and respective patient outcomes.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription